ID
39612
Beschrijving
Study ID: 110852 Clinical Study ID: 110852 Study Title: MD7110852, A Phase 2b Dose-Ranging Study of Pazopanib Eye Drops versus Ranibizumab Intravitreal Injections for the Treatment of Neovascular Age-Related Macular Degeneration Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01134055 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: pazopanib eye drops, ranibizumab intravitreal injection, placebo Trade Name: pazopanib, ranibizumab Study Indication: Macular Degeneration
Trefwoorden
Versies (1)
- 03-02-20 03-02-20 -
Houder van rechten
GlaxoSmithKline
Geüploaded op
3 februari 2020
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Pazopanib Eye Drops versus Ranibizumab Intravitreal Injections for the Treatment of Neovascular Age-Related Macular Degeneration NCT01134055
Screen - Re-Screening data; Study Eye; Ranibizumab Injection
- StudyEvent: ODM
Beschrijving
Study Eye
Alias
- UMLS CUI-1
- C0008972
- UMLS CUI-2
- C0015392
Beschrijving
Ranibizumab Injection
Alias
- UMLS CUI-1
- C1566537
- UMLS CUI-2
- C1272883
Similar models
Screen - Re-Screening data; Study Eye; Ranibizumab Injection
- StudyEvent: ODM
C2347804 (UMLS CUI [1,2])
C2347804 (UMLS CUI [1,2])
C2348585 (UMLS CUI [2])
C0015392 (UMLS CUI [1,2])
C0205396 (UMLS CUI [1,3])
C1272883 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0040223 (UMLS CUI [1,4])
C0008972 (UMLS CUI [2,1])
C0015392 (UMLS CUI [2,2])